Report: AI Powered Review on GeoVax (GOVX) $1.15

In our view, a research report is designed to gather information on publicly traded companies from press releases, management presentations (including power points), SEC...

GeoVax (GOVX) Reports Both Favorable Safety and “It’s Working” News for its Cancer...

Official Headline is "GeoVax Announces JCO Oncology Advances Publication Highlighting Favorable Safety and Evidence of Disease Stability of Gedeptin(R) in Recurrent Head & Neck...
DAVID DODD GEOVAX

Op-Ed: Why the US Must Move Beyond Its mRNA Monoculture

BioPharm David Dodd, GeoVax Labs (NASDAQ: GOVX), opines on why vaccine platform diversity is critical in the United States. Editor's Note: The views an opinions expressed...

TWO DOUBLES, From the Same Stock! Bavarian Nordic (BVRNY) $12.25, gains 149% After Adding...

Been quite sometime since we had Watch List company taken out, at over $1 Billion but here we go again. With our 4th billion...

GeoVax (GOVX) Accelerates Development of GEO-MVA Vaccine Amid Expanding Global Mpox Crisis and Reaffirmed...

EMA Scientific Guidance, Global Surge in Clade I Mpox, and Aid Shortfalls Drive Urgent Need for Scalable, Equitable Vaccine Solutions LIVE QUOTE ATLANTA, GA - July...

Adding Bavarian Nordic (BVNRY) to Watch List $7.36. Freeze Dries its MPOX Vaccine!

This is Big News, Honestly. We Are Adding to 2025 Watch List @ $7.36. We last added Bavarian to the 2020 Biotech Watch List and...

Vaccine Biotechs Hammered After FDA Official Resigns, Citing RFK Jr.’s ‘Misinformation And Lies’ (IBD)

Sorting Through the Wreckage! Full post on Investor's Business Daily. Biotech stocks took a beating Monday after Peter Marks, a top Food and Drug Administration official,...

We’re Back! And We’re Adding (again), GeoVax (GOVX), the Alkaline Water Co (WTER) and...

GeoVax (GOVX) $1.64. Recent High $11.18 (BiotechStockReview) The Alkaline Water Co. (WTER) $0.09. Recent High $0.48 (BeverageStockReview) Society Pass (SOPA) $1.27. Recent High $6.75. (InternetStockReview) Okay we're...

Nine Page Summary Report on GeoVax (GOVX)

This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier 44-page report, we printed it out and...

GeoVax (GOVX) Provides First Half 2024 Business Update.

Award of BARDA Project NextGen contract represents a significant milestone event; Total value of award to GeoVax and its CRO partner total approximately $367-388 million BARDA-funded...

Latest article

GeoVax (GOVX) Surges 51% on Massive Volume Spike.

MonkeyPox and Gedeptin Related News Spark New Investor Interest. MARKET BRIEF On a quiet Thursday afternoon, the 30th, while we were nearing completion of an updated...

Paving Past Obstacles on the Path to US Biosecurity

GeoVax’s CEO calls on government support to bolster domestic biotechnology and keep pace with China. National biosecurity has become a frequent topic of conversation in...

Dinner Presentation With BioStem Technologies, Inc. (BSEM) in Boca Raton, FL

LIVE QUOTE LONGER TERM CHART Contact Ray Oliver at Bear Creek Capital for details. RECENT NEWS PRESENTATION https://youtu.be/Au-pIqDHyto?si=_JKFAhwT-vvLSFqe WOUND CARE REPORT Global Wound Care Market to Reach USD 30.48 Billion by...